GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Applied DNA Sciences Inc (FRA:UDJ) » Definitions » Cyclically Adjusted Price-to-FCF

Applied DNA Sciences (FRA:UDJ) Cyclically Adjusted Price-to-FCF : (As of May. 26, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Applied DNA Sciences Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Applied DNA Sciences Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Applied DNA Sciences's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Applied DNA Sciences Cyclically Adjusted Price-to-FCF Chart

Applied DNA Sciences Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Applied DNA Sciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Applied DNA Sciences's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, Applied DNA Sciences's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Applied DNA Sciences's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Applied DNA Sciences's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Applied DNA Sciences's Cyclically Adjusted Price-to-FCF falls into.



Applied DNA Sciences Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Applied DNA Sciences's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Applied DNA Sciences's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-3.39/131.7762*131.7762
=-3.390

Current CPI (Mar. 2024) = 131.7762.

Applied DNA Sciences Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -86.941 100.560 -113.930
201409 -102.353 100.428 -134.302
201412 -100.579 99.070 -133.784
201503 -67.864 99.621 -89.769
201506 -41.407 100.684 -54.194
201509 -57.370 100.392 -75.305
201512 -91.393 99.792 -120.685
201603 -77.933 100.470 -102.216
201606 -80.067 101.688 -103.758
201609 -77.000 101.861 -99.614
201612 -62.563 101.863 -80.936
201703 -75.970 102.862 -97.325
201706 -50.818 103.349 -64.796
201709 -23.412 104.136 -29.626
201712 -63.286 104.011 -80.180
201803 -18.395 105.290 -23.022
201806 -26.895 106.317 -33.335
201809 -56.500 106.507 -69.905
201812 -36.237 105.998 -45.050
201903 -48.476 107.251 -59.561
201906 -23.729 108.070 -28.934
201909 -30.434 108.329 -37.021
201912 -20.655 108.420 -25.105
202003 -11.649 108.902 -14.096
202006 -11.668 108.767 -14.136
202009 -9.856 109.815 -11.827
202012 -13.505 109.897 -16.194
202103 -9.467 111.754 -11.163
202106 -4.019 114.631 -4.620
202109 -12.733 115.734 -14.498
202112 -9.008 117.630 -10.091
202203 -0.738 121.301 -0.802
202206 -3.857 125.017 -4.066
202209 -6.249 125.227 -6.576
202212 -3.488 125.222 -3.671
202303 0.310 127.348 0.321
202306 -1.960 128.729 -2.006
202309 -3.698 129.860 -3.753
202312 -5.038 129.419 -5.130
202403 -3.390 131.776 -3.390

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Applied DNA Sciences  (FRA:UDJ) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Applied DNA Sciences Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Applied DNA Sciences's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Applied DNA Sciences (FRA:UDJ) Business Description

Traded in Other Exchanges
Address
50 Health Sciences Drive, Stony Brook, New York, NY, USA, 11790
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

Applied DNA Sciences (FRA:UDJ) Headlines

No Headlines